These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5404003)

  • 21. Effect of reserpine on accumulation and removal of d-amphetamine- 3 H.
    Stolk JM; Rech RH
    Biochem Pharmacol; 1969 Oct; 18(10):2786-8. PubMed ID: 5404008
    [No Abstract]   [Full Text] [Related]  

  • 22. "FALSE NEUROCHEMICAL TRANSMITTERS" AND THE MECHANISM OF SYMPATHETIC BLOCKADE BY MONOAMINE OXIDASE INHIBITORS.
    KOPIN IJ; FISCHER JE; MUSACCHIO JM; HORST WD; WEISE VK
    J Pharmacol Exp Ther; 1965 Feb; 147():186-93. PubMed ID: 14259496
    [No Abstract]   [Full Text] [Related]  

  • 23. Depletion and recovery of catecholamines in several organs of rats treated with reserpine.
    Martínez-Olivares R; Villanueva I; Racotta R; Piñón M
    Auton Neurosci; 2006 Jul; 128(1-2):64-9. PubMed ID: 16723281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1965 Nov; 150(2):173-83. PubMed ID: 4379176
    [No Abstract]   [Full Text] [Related]  

  • 25. Storage and synthesis of norepinephrine in the reserpine-treated rat brain.
    Glowinski J; Iversen LL; Axelrod J
    J Pharmacol Exp Ther; 1966 Mar; 151(3):385-99. PubMed ID: 4380046
    [No Abstract]   [Full Text] [Related]  

  • 26. Uptake of biogenic amines by two different mechanisms present in adrenergic granules.
    Lundborg P; Stitzel R
    Br J Pharmacol Chemother; 1967 Mar; 29(3):342-9. PubMed ID: 6034383
    [No Abstract]   [Full Text] [Related]  

  • 27. Disposition of norepinephrine-H3 in sympathetic ganglia.
    Fischer JE; Snyder S
    J Pharmacol Exp Ther; 1965 Nov; 150(2):190-5. PubMed ID: 5855876
    [No Abstract]   [Full Text] [Related]  

  • 28. The chemorelease of norepinephrine from mouse hearts. IV. Structure-activity relationships. Reserpines and yohimbines.
    Creveling CR; Daly JW; Parfitt RT; Witkop B
    J Med Chem; 1968 May; 11(3):596-8. PubMed ID: 5656504
    [No Abstract]   [Full Text] [Related]  

  • 29. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 30. Reserpine-induced depletion of the norepinephrine stores: is it a reliable criterion for the classification of the mechanism of action of sympathomimetic amines?
    Luchelli-Fortis MA; Langer SZ
    J Pharmacol Exp Ther; 1974 Mar; 188(3):640-53. PubMed ID: 4816331
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of nerve stimulation on the depletion of noradrenaline by reserpine in the heart, vas deferens and anococcygeus muscle of the rat.
    Gillespie JS; McGrath JC
    Br J Pharmacol; 1972 Nov; 46(3):525P-526P. PubMed ID: 4511873
    [No Abstract]   [Full Text] [Related]  

  • 32. Difference in the turnover of noradrenaline in rat heart during day and night.
    Lemmer B; Saller R
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):107-9. PubMed ID: 4267961
    [No Abstract]   [Full Text] [Related]  

  • 33. The similar pharmacologic effects of pentaborane, decaborane and reserpine.
    Weir FW; Meyers FH
    Ind Med Surg; 1966 Aug; 35(8):696-701. PubMed ID: 5223447
    [No Abstract]   [Full Text] [Related]  

  • 34. Brain serotonin and norepinephrine after convulsions and reserpine.
    Feighner JP; Lao L; King LJ; Ross WJ
    J Neurochem; 1972 Mar; 19(3):905-7. PubMed ID: 5030993
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices.
    Ng KY; Chase TN; Kopin IJ
    Nature; 1970 Oct; 228(5270):468-9. PubMed ID: 5482502
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of levodopa on the norepinephrine stores in rat heart.
    Liu PL; Krenis LJ; Ngai SH
    Anesthesiology; 1971 Jan; 34(1):4-8. PubMed ID: 5540365
    [No Abstract]   [Full Text] [Related]  

  • 37. Retention of exogenous norepinephrine and recovery of the responses to tyramine and 1,1-dimethyl-4-phenylpiperazinium iodide after reserpine.
    Bhagat B; Bhattacharya IC; Dhalla NS
    J Pharmacol Exp Ther; 1966 Sep; 153(3):434-9. PubMed ID: 5922321
    [No Abstract]   [Full Text] [Related]  

  • 38. Circadian changes in norepinephrine turnover in rats following administration of estrogen.
    Lew GM
    Gen Pharmacol; 1979; 10(2):127-31. PubMed ID: 437480
    [No Abstract]   [Full Text] [Related]  

  • 39. A note on the blockade of uptake of noradrenaline by 4-chloro-alpha,alpha-dimethylphenethylaminopropan-2-one in rodents.
    Lippmann W
    J Pharm Pharmacol; 1968 May; 20(5):385-9. PubMed ID: 4385444
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.